Pardeep Nijhawan Edesa Biotech, Inc. (EDSA) insider trading activity

Pardeep Nijhawan is Chief Executive Officer of Edesa Biotech, Inc.. Currently has a direct ownership of 449,767 shares of EDSA, which is worth approximately $895,036. The most recent transaction as insider was on Jun 02, 2025, when has been sold 7,644 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 450K

169.73% 3M change

278.17% 12M change

Total Value Held $895,036

Pardeep Nijhawan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2025	BUY Grant, award, or other acquisition	-	7,644 Added 1.67%	449,767 Common Shares
May 29 2025	BUY Grant, award, or other acquisition	-	263,200 Added 37.32%	442,123 Common Shares
May 02 2025	BUY Grant, award, or other acquisition	-	6,392 Added 3.45%	178,923 Common Shares
Apr 01 2025	BUY Grant, award, or other acquisition	-	5,784 Added 3.24%	172,531 Common Shares
Mar 03 2025	BUY Grant, award, or other acquisition	-	6,339 Added 3.66%	166,747 Common Shares
Feb 03 2025	BUY Grant, award, or other acquisition	-	8,264 Added 4.9%	160,408 Common Shares
Jan 06 2025	BUY Grant, award, or other acquisition	-	8,476 Added 5.28%	152,144 Common Shares
Dec 02 2024	BUY Grant, award, or other acquisition	-	6,420 Added 4.28%	143,668 Common Shares
Nov 12 2024	BUY Grant, award, or other acquisition	-	4,630 Added 3.26%	137,248 Common Shares
Oct 02 2024	BUY Grant, award, or other acquisition	-	3,300 Added 2.43%	132,618 Common Shares
Sep 03 2024	BUY Grant, award, or other acquisition	-	3,055 Added 2.31%	129,318 Common Shares
Aug 01 2024	BUY Grant, award, or other acquisition	-	3,317 Added 2.56%	126,263 Common Shares
Jul 02 2024	BUY Grant, award, or other acquisition	-	4,015 Added 3.16%	122,946 Common Shares
Jun 03 2024	BUY Grant, award, or other acquisition	-	4,785 Added 3.87%	118,931 Common Shares
May 01 2024	BUY Grant, award, or other acquisition	-	3,083 Added 2.63%	114,146 Common Share
Apr 01 2024	BUY Grant, award, or other acquisition	-	3,253 Added 2.85%	111,063 Common Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	2,765 Added 2.5%	107,810 Common Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	2,978 Added 2.76%	105,045 Common Shares
Jan 08 2024	BUY Grant, award, or other acquisition	-	2,908 Added 2.77%	102,067 Common Shares
Aug 04 2023	BUY Grant, award, or other acquisition	-	99,300 Added 12.52%	694,112 Common Shares
Jun 30 2022	BUY Open market or private purchase	$32,000 $1.6 p/Share	20,000 Added 3.25%	594,812 Common Shares
May 27 2022	BUY Open market or private purchase	$9,600 $1.92 p/Share	5,000 Added 0.86%	574,812 Common Shares
May 24 2022	BUY Open market or private purchase	$3,600 $1.8 p/Share	2,000 Added 0.35%	569,812 Common Shares
Mar 31 2022	BUY Open market or private purchase	$5,980 $2.99 p/Share	2,000 Added 0.35%	567,812 Common Shares
Mar 30 2022	BUY Open market or private purchase	$6,100 $3.05 p/Share	2,000 Added 0.35%	565,812 Common Shares

Pardeep Nijhawan

Chief Executive Officer

Markham, A6

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDSA shares.

Notify only if

Value

Insider Trading

Get notified when an Edesa Biotech, Inc. insider buys or sells EDSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edesa Biotech, Inc.

Track Activities on EDSA

Account